Owen A Ross Selected Research

Parkinsonian Disorders (Parkinsonism)

1/2022	L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome.
12/2021	Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review.
1/2021	Early-Onset Parkinsonism and Early-Onset Parkinson's Disease: A Population-Based Study (2010-2015).
12/2020	Association of mitochondrial genomic background with risk of Multiple System Atrophy.
1/2020	Cognitive and behavioral profile of Perry syndrome in two families.
1/2019	Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.
1/2018	Establishing diagnostic criteria for Perry syndrome.
8/2016	TREM2 p.R47H substitution is not associated with dementia with Lewy bodies.
6/2016	α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.
1/2016	Autosomal dominant Parkinson's disease caused by SNCA duplications.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Owen A Ross Research Topics

Disease

71	Parkinson Disease (Parkinson's Disease) 06/2022 - 09/2002
33	Parkinsonian Disorders (Parkinsonism) 01/2022 - 04/2005
16	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2007
15	Dementia (Dementias) 01/2022 - 05/2007
14	Lewy Body Disease (Lewy Body Dementia) 01/2022 - 07/2009
10	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 05/2007
8	Multiple System Atrophy 01/2021 - 08/2007
8	Essential Tremor (Essential Tremors) 12/2016 - 09/2009
7	Tremor (Tremors) 01/2022 - 04/2010
7	Synucleinopathies 12/2021 - 01/2014
6	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2020 - 03/2007
5	Cognitive Dysfunction 01/2022 - 11/2009
5	Tauopathies 01/2022 - 10/2014
5	Dystonia (Limb Dystonia) 01/2022 - 05/2007
5	Stroke (Strokes) 03/2021 - 05/2010
5	Ischemic Stroke 03/2021 - 01/2013
4	Dyskinesias (Dyskinesia) 01/2022 - 04/2010
4	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021 - 05/2007
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 03/2014
4	Corticobasal Degeneration 12/2020 - 08/2012
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2015 - 08/2011
4	Mitochondrial Diseases (Mitochondrial Disease) 11/2014 - 04/2003
3	Atrophy 01/2021 - 03/2014
2	Disease Progression 01/2022 - 01/2022
2	Transient Ischemic Attack 03/2021 - 01/2020
2	Movement Disorders (Movement Disorder) 01/2021 - 10/2016
2	Disease Susceptibility (Diathesis) 01/2021 - 10/2013
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021 - 08/2011
2	Gliosis 01/2020 - 05/2019
2	Proteostasis Deficiencies 01/2019 - 10/2014
2	REM Sleep Behavior Disorder 07/2017 - 08/2016
2	Frontotemporal Dementia (Semantic Dementia) 09/2015 - 08/2012
1	Genetic Risk Score 01/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2021
1	Hemorrhage 03/2021
1	Pick Disease of the Brain (Pick's Disease) 01/2021
1	Amyloidosis 01/2021
1	Ataxia (Dyssynergia) 12/2020
1	Brain Injuries (Brain Injury) 11/2020
1	Ischemia 01/2020
1	Hippocampal Sclerosis 01/2019
1	Neuroinflammatory Diseases 10/2018
1	Rheumatoid Arthritis 01/2018
1	Atherosclerosis 01/2018
1	Inflammation (Inflammations) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Weight Loss (Weight Reduction) 01/2018

Drug/Important Bio-Agent (IBA)

21	Phosphotransferases (Kinase)IBA 01/2021 - 04/2005
19	SynucleinsIBA 01/2022 - 08/2010
18	Leucine (L-Leucine)FDA Link 01/2021 - 04/2005
14	Proteins (Proteins, Gene)FDA Link 03/2022 - 09/2005
12	Apolipoproteins E (ApoE)IBA 01/2022 - 03/2007
11	Amyloid (Amyloid Fibrils)IBA 01/2022 - 05/2015
11	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2020 - 05/2011
10	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 11/2009
10	alpha-SynucleinIBA 12/2020 - 09/2002
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2009
7	Mitochondrial DNA (mtDNA)IBA 01/2022 - 04/2003
6	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020 - 06/2010
5	ApolipoproteinsIBA 01/2022 - 03/2014
3	NucleotidesIBA 01/2021 - 01/2019
3	UbiquitinIBA 01/2021 - 05/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 07/2009
2	Apolipoprotein E4IBA 01/2022 - 01/2020
2	Apolipoprotein E3IBA 09/2021 - 01/2020
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
2	Serine (L-Serine)FDA Link 01/2021 - 01/2018
2	Biological ProductsIBA 01/2020 - 02/2014
2	CytokinesIBA 01/2018 - 09/2007
2	PTEN-induced putative kinaseIBA 01/2017 - 11/2014
2	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 01/2016 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 01/2016 - 06/2014
2	Amino Acids FDA Link 08/2015 - 01/2013
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 08/2015 - 05/2011
2	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 03/2014 - 10/2009
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2014 - 01/2014
2	EnzymesIBA 03/2012 - 11/2011
2	Leucine-Rich Repeat Serine-Threonine Protein Kinase-2IBA 07/2009 - 10/2007
1	Cathepsin BIBA 06/2022
1	Poly Adenosine Diphosphate RiboseIBA 01/2022
1	IGF-I-IGFBP-3 complex FDA Link 01/2022
1	Cilostazol (Pletal)FDA LinkGeneric 03/2021
1	tributyl phosphate (TBP)IBA 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2021
1	Clopidogrel (Plavix)FDA Link 01/2020
1	Cytochrome P-450 CYP2C19IBA 01/2020
1	ethyl 4-azidophenyl-1,4-dithiobutyrimidateIBA 01/2020
1	Apolipoprotein E2IBA 01/2020
1	pericentrinIBA 12/2018
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2018
1	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 01/2018
1	InflammasomesIBA 01/2018
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/2017
1	3-Iodobenzylguanidine (Iobenguane)IBA 07/2017
1	Phospholipid Transfer ProteinsIBA 12/2016

Therapy/Procedure

7	Therapeutics 12/2021 - 01/2016
1	Precision Medicine 01/2022
1	Ligation 01/2021